Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;29(1):64-70.
doi: 10.1097/MNH.0000000000000571.

Intestinal dialysis for conservative management of Uremia

Isha Puri  1 , Nasser Majid Shirazi, Ernie Yap, Subodh J Saggi
Affiliations
Review

Intestinal dialysis for conservative management of Uremia

Isha Puri et al. Curr Opin Nephrol Hypertens. 2020 Jan.

Abstract

Purpose of review: Renal replacement therapies, such as hemodialysis are invasive and impose significant financial burden as well as burden on quality of life. Conservative and 'gentler' forms of renal replacement therapy for the frail and palliative care patient is an unmet medical need.

Recent findings: The treatment of uremia using the gut as a substitute for the kidney has been proposed but is not practiced widely because of proven lack of long-term mortality benefit coupled with complications like edema and hyperchloremia. Mounting evidence showed that endotoxins from gastrointestinal tract are a major source of chronic inflammation in chronic kidney disease (CKD). The high load of nitrogenous waste elimination through the bowel could potentially serve as an alternative modality to remove uremic wastes especially in people who opt for conservative management for end-stage renal disease with some recent studies in Iran and China showing promising benefits in uremia.

Summary: In this review, we will discuss the history, recent evidence and potential of these therapies and their implications in CKD for conservative and easy management of uremia.

PubMed Disclaimer

References

    1. Evenepoel P, Meijers BK, Bammens BR, Verbeke K. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 2009; (114):S12–S19.
    1. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007; 357:1316–1325.
    1. Motojima M, Hosokawa A, Yamato H, et al. Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J Pharmacol 2002; 135:555–563.
    1. Lysaght MJ, Vonesh EF, Gotch F, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37:598–604.
    1. Miyazaki T, Ise M, Hirata M, et al. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int Suppl 1997; 62:S15–S22.

MeSH terms

LinkOut - more resources